RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

IMS Health Incorporated

A collection of news and information related to IMS Health Incorporated published by this site and its partners.

Top IMS Health Incorporated Articles

Displaying items 12-22
  • Diabetes cases hit record and half go undiagnosed

    Diabetes cases hit record and half go undiagnosed
    LONDON (Reuters) - Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed, according to a report on Wednesday. The number of people living with diabetes is now put at 371 million, up from...
  • The Big One is going generic

     
    The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
  • FDA: "Female Viagra" Results Not Compelling

    FDA: "Female Viagra" Results Not Compelling
    WASHINGTON -- A pink pill designed to boost sex drive in women -- the latest attempt by the drug industry to find a female equivalent to Viagra -- fell short in two studies, federal health regulators said Wednesday. The Food and Drug Administration is...
  • FDA: Avandia Should Stay With Restrictions

    FDA: Avandia Should Stay With Restrictions
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
  • Effectiveness of statins called into question

    Effectiveness of statins called into question
    As the world's most-prescribed class of medications, statins indisputably qualify for the commercial distinction of "blockbuster." About 24 million Americans take the drugs — marketed under such commercial names as Pravachol, Mevacor, Lipitor, Zocor...
  • Newer antipsychotics overused, US study suggests

    Newer antipsychotics overused, US study suggests
    Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday. The drugs, known as "atypical...
  • Brain shrinkage seen in those taking antipsychotic medications

    A new study finds that one the fastest-growing classes of prescription drugs in the United States is linked to shrinkage in the brains of those who take it, raising some new questions about the widening use of antipsychotic medications.       Over a...
  • Diet drugs face tough test

    Diet drugs face tough test
    There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...
  • Glaxo adds safety restrictions to Avandia label

    Glaxo adds safety restrictions to Avandia label
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
  • Diabetes 'massive challenge' as cases hit 366 million

    Diabetes 'massive challenge' as cases hit 366 million
    LONDON (Reuters) - The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare systems worldwide, experts said on Tuesday. The vast majority of...
  • Sleeping pills linked to higher risk of cancer, death, study says

    Sleeping pills linked to higher risk of cancer, death, study says
    A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...